Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Klarity connects you with healthcare providers to create a personalized plan and offers insights into 10 GLP-1 medications ... a full list of side effects. Zepbound is a GLP-1 agonist ...

Zepbound (tirzepatide ... researchers found that tirzepatide in doses of 5, 10, and 15 milligrams (mg) resulted in significant and sustained weight loss. The study, which had support from the ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Likewise, the injected Zepbound® resulted in 22 gastrointestinal ("GI")-related adverse events, whereas the oral DehydraTECH-tirzepatide resulted in only 10 GI-related ... in mg/dL) were 88.2 ...